GURU.Markets stock price, segment price, and overall market index valuation
The company's share price CeriBell Inc.
CeriBell, the developer of an innovative brain activity monitoring system, is valued in the private market by its potential to change the standard of treatment for epileptic seizures. Its potential share price will depend on the adoption of its technology in hospitals.
Share prices of companies in the market segment - Neuro
CeriBell has developed an innovative rapid EEG monitoring system that allows doctors in intensive care units to quickly diagnose and treat seizures. We classify it as part of the Neurology sector. The graph below shows the growth of this cutting-edge medical segment.
Broad Market Index - GURU.Markets
CeriBell is a medical company that has developed a portable device for rapid diagnosis and monitoring of epileptic seizures. As an innovator in this field, it is included in our GURU.Markets index. The chart below shows the overall market trend. See how investors are valuing this breakthrough technology.
Change in the price of a company, segment, and market as a whole per day
CBLL - Daily change in the company's share price CeriBell Inc.
The daily price change of CeriBell, a developer of brain monitoring systems, reflects innovations in neuroscience. Change_co shows sensitivity to regulatory approvals and market acceptance of the technology. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Neuro
The medical technology sector in which CeriBell, Inc. operates is highly dynamic. This chart reflects the average volatility of the industry. It serves as a benchmark for assessing how sensitive CeriBell's epilepsy diagnostic business is to overall trends and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Ceribell is a private company that has developed a portable EEG device for rapid seizure diagnosis. Its potential IPO will depend heavily on the market's appetite for medical technology innovation. The chart below shows the general volatility that influences the fate of such "unicorns."
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization CeriBell Inc.
CeriBell, Inc.'s year-over-year performance tells the story of its innovative system for rapid seizure diagnosis. Its 12-month market capitalization reflects the success of its portable EEG systems in emergency and intensive care units, fundamentally changing the speed and accessibility of critical brain diagnosis.
Annual dynamics of market capitalization of the market segment - Neuro
Ceribell, a privately held company, produces a revolutionary system for the rapid diagnosis of epileptic seizures. Its growth, as demonstrated by hospital adoption, is likely significantly outpacing the medical equipment sector, as it addresses a critical and previously unmet medical need.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
CeriBell is privately held and not publicly traded. Its market performance cannot be analyzed. As a developer of a rapid EEG system for emergency medicine, its business is at the forefront of medical technology. Its success is determined by clinical data and its ability to bring its product to market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization CeriBell Inc.
CeriBell's value as a medical diagnostics company will depend on the adoption of its technology. Monthly fluctuations on the chart will reflect the growing number of hospitals using its rapid EEG monitoring system and reimbursement decisions by insurance companies.
Monthly dynamics of market capitalization of the market segment - Neuro
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures right at the patient's bedside. This portable EEG device saves precious time in critical situations. The graph below shows the dynamics of the medical equipment sector, where speed of diagnosis can save lives.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
CeriBell is developing an innovative system for the rapid diagnosis and monitoring of epileptic seizures. As a medical startup, the company is entirely dependent on the success of its product and its clinical implementation. Its stock is driven by sales and research news, ignoring overall market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization CeriBell Inc.
CeriBell develops portable systems for monitoring brain activity (EEG). The medtech company's weekly stock price reflects the pace of its technology's adoption in emergency and intensive care units, as well as news of its clinical effectiveness.
Weekly dynamics of market capitalization of the market segment - Neuro
CeriBell, like other companies in the innovative medical equipment sector, is dependent on general factors such as the pace of new technology adoption in hospitals and insurance company policies. The chart compares the company's performance with the overall health of its medical segment.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
CeriBell develops innovative brain monitoring systems. As a medical technology company, it should be less dependent on the economy. The chart will show how insulated its shares are from market fluctuations, moving in sync with news about the implementation of its technologies in hospitals, rather than driven by macroeconomic data.
Market capitalization of the company, segment and market as a whole
CBLL - Market capitalization of the company CeriBell Inc.
The data for CeriBell, Inc. (CBLL) may be inaccurate, as it is likely a private company. If it were publicly traded, its market capitalization would reflect investors' faith in its innovative system for rapidly diagnosing epileptic seizures and its potential to change the standard of care in neurology.
CBLL - Share of the company's market capitalization CeriBell Inc. within the market segment - Neuro
CeriBell, Inc. is seeking to capture market share in neurological diagnostics with its innovative rapid EEG monitoring system. Its market cap reflects the potential of its device for rapid seizure diagnosis in emergency departments.
Market capitalization of the market segment - Neuro
CeriBell has developed a portable EEG for rapid diagnostics. What is the size of the neurotechnology market? The graph below shows the total market capitalization of this sector. Its growth reflects the enormous need for innovation in the diagnosis and treatment of brain diseases, where speed is crucial.
Market capitalization of all companies included in a broad market index - GURU.Markets
CeriBell's chart is a bet on a revolution in epilepsy diagnostics. The market cap of the company, which created a portable EEG monitor for intensive care, reflects investors' faith in its ability to change the standard of care. It's a visualization of the medical startup's long journey from innovative idea to widespread clinical application.
Book value capitalization of the company, segment and market as a whole
CBLL - Book value capitalization of the company CeriBell Inc.
For CeriBell, the creator of an innovative rapid EEG monitoring system, book value is its tangible assets: production lines for assembling devices, R&D laboratories, and component inventory. The chart below shows how the company grew its physical capital to revolutionize epilepsy diagnostics.
CBLL - Share of the company's book capitalization CeriBell Inc. within the market segment - Neuro
CeriBell, Inc. is creating a revolutionary device for epilepsy diagnostics. Its tangible assets include production lines for portable EEG systems and headbands. These facilities are the physical source of a new era in neuroscience. The graph shows the share of its manufacturing base in the niche but growing neurodiagnostic sector.
Market segment balance sheet capitalization - Neuro
CeriBell has developed a portable EEG device. The medical equipment sector, as the chart shows, is capital-intensive. CeriBell is an innovator. Its capital has been invested in R&D and production of a unique device that is changing the approach to neurological diagnostics.
Book value of all companies included in the broad market index - GURU.Markets
CeriBell's core business is the production capacity for a unique portable EEG device for rapid diagnostics in emergency departments. The chart below shows how the company expanded its production capabilities for this innovative medical device.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - CeriBell Inc.
CeriBell's assets are manufacturing facilities. But the market is paying a premium for their breakthrough device, which enables rapid diagnosis of epileptic seizures. The chart below shows how the market valued this life-saving medical innovation.
Market to book capitalization ratio in a market segment - Neuro
CeriBell has developed a portable device for rapid diagnosis of epileptic seizures. Its value lies in this breakthrough technology. The chart shows how its market capitalization, based on its potential to change standards of care, exceeds its current assets.
Market to book capitalization ratio for the market as a whole
CeriBell has developed a portable device for rapid diagnosis of epileptic seizures. Its valuation, unlike the average in this chart, is based on its innovative technology and potential to change the standard of care in emergency departments. The market views it as a fast-growing medical company solving a critical problem.
Debts of the company, segment and market as a whole
CBLL - Company debts CeriBell Inc.
CeriBell is developing an innovative system for rapid EEG monitoring, enabling the prompt diagnosis of seizures. This chart reflects the growing medical company's financial strategy. The capital raise is being used to expand its commercial team and market penetration, making its device a standard in emergency departments.
Market segment debts - Neuro
CeriBell is developing and commercializing an innovative system for rapid electroencephalogram (EEG) monitoring in intensive care units, enabling the rapid detection of seizures. This chart illustrates how the company's leveraged position, which is currently in the commercialization stage, reflects its strategy for bringing this new technology into clinical practice.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio CeriBell Inc.
CeriBell develops innovative systems for monitoring brain activity. As a company at the intersection of medicine and high technology, it requires significant investment in R&D and commercialization. This chart shows how much CeriBell relies on debt to finance its growth, a key factor in assessing its financial stability.
Market segment debt to market segment book capitalization - Neuro
CeriBell has developed a portable system for rapid diagnosis of epileptic seizures. This chart shows the debt burden in the neurotechnology sector. It helps understand how companies in this cutting-edge field of medicine finance their research, development, and commercialization of life-saving devices.
Debt to book value of all companies in the market
CeriBell is developing an innovative system for the rapid diagnosis of epileptic seizures. Like many medical tech startups, the company requires significant investment to commercialize its product. This chart of total market debt demonstrates how favorable the business environment is overall to funding such risky but promising tech companies.
P/E of the company, segment and market as a whole
P/E - CeriBell Inc.
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures using a portable EEG device. This chart reflects investors' belief that this technology will transform the standards of emergency neurological care. The pace of implementation depends on the system's adoption in hospitals and its commercial success.
P/E of the market segment - Neuro
CeriBell developed and commercialized the world's first system for rapid diagnosis and monitoring of epileptic seizures using a portable EEG device. This allows doctors to make rapid decisions in critical situations. This chart shows the overall rating for the neuroscience sector, reflecting how the market values breakthrough technologies in brain disease diagnostics.
P/E of the market as a whole
CeriBell (privately held, ticker symbol CBLL may be misleading) is developing a portable system for rapid diagnosis of epileptic seizures using EEG. Its valuation is a bet on the adoption of this innovative technology in emergency departments. Its valuation is not dependent on general economic cycles, but is determined by the proven effectiveness of its product and hospital purchasing decisions.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company CeriBell Inc.
CeriBell, Inc. has developed a portable system for rapid diagnosis and monitoring of epileptic seizures right at the patient's bedside. This graph reflects the expected adoption of this innovative device in hospitals. The company's valuation is a bet that its technology will become a new standard in emergency neurology.
%20P%2FE%20CeriBell%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-CeriBell-Inc.&v=1772556834814 "Chart of the company's future (projected) P/E CeriBell Inc.")
Future (projected) P/E of the market segment - Neuro
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures using a portable EEG device. This chart reflects the market's confidence in the widespread adoption of this technology in hospitals. Comparing its profit forecasts with the medical equipment sector shows how highly investors value its potential to transform treatment standards.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Neuro&v=1772556834828 "Future (projected) P/E graph of the market segment - Neuro")
Future (projected) P/E of the market as a whole
CeriBell has developed an innovative system for rapid diagnosis of epileptic seizures using a portable EEG. This is a breakthrough technology for emergency medicine. Amid the general market fluctuations shown by this chart, CeriBell's story is a bet that its technology will become a new standard in neurological diagnostics.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772556834863 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit CeriBell Inc.
CeriBell, Inc. is developing and commercializing an innovative system for rapid brain activity (EEG) monitoring in intensive care units. The company's profitability depends on the adoption of its technology in hospitals. This chart shows the path to profitability for a medical company offering a new solution for critical diagnostics.
Profit of companies in the market segment - Neuro
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures right at the patient's bedside. The company aims to change the standard of care in neurology. This neurotechnology profitability chart demonstrates the willingness of the medical community and investors to invest in cutting-edge technologies to solve complex neurological problems.
Overall market profit
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures using a portable EEG. The company solves a critical problem in neurology, enabling doctors to make faster decisions. Its growth exemplifies how medical technology startups can dramatically improve the quality of treatment and create a new market niche.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company CeriBell Inc.
CeriBell has developed an innovative system for rapid diagnosis of epileptic seizures using a portable EEG. This graph shows the expected commercialization and adoption of this technology in emergency departments. Future revenue depends on the speed of adoption of the device in hospitals worldwide.
%20profit%20of%20the%20company%20CeriBell%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-CeriBell-Inc.&v=1772556834965 "Graph of future (projected) profit of the company CeriBell Inc.")
Future (predicted) profit of companies in the market segment - Neuro
CeriBell, Inc. has developed a portable system for rapid diagnosis and monitoring of epileptic seizures. This graph reflects profitability forecasts for the medical technology sector. It provides an opportunity to assess how an innovative product solving a pressing medical problem could change treatment standards and its market prospects.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Neuro&v=1772556834980 "Graph of future (predicted) profits of companies in a market segment - Neuro")
Future (predicted) profit of the market as a whole
The trajectory on this chart shows the expectations for a medical company that has developed a portable system for rapid diagnosis of epileptic seizures. CeriBell's profit forecast depends on the adoption of its technology in emergency and intensive care units. This is a bet on innovations in neurology that have the potential to change the standard of care.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772556835004 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - CeriBell Inc.
CeriBell is developing an innovative system for the rapid diagnosis of epileptic seizures. At the commercialization stage, revenue is a key indicator of its success. This chart shows the premium investors are paying for its sales, believing in the potential of its technology to become a new standard in neurology.
P/S market segment - Neuro
CeriBell has developed an innovative system for the rapid diagnosis and monitoring of epileptic seizures. The company's revenue depends on the adoption of its technology in hospitals and emergency services. This chart shows the average valuation in the neurological medical equipment sector, reflecting how highly the market perceives CeriBell's potential for revenue generation in this niche.
P/S of the market as a whole
CeriBell has developed a portable system for rapid, point-of-care diagnosis of epileptic seizures. This innovative product addresses a critical need in neurology. This graph, showing CeriBell's average revenue estimate, helps us understand the market premium the company is willing to pay for medical technologies that could change the standard of care.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company CeriBell Inc.
CeriBell has developed a portable system for rapid diagnosis and monitoring of epileptic seizures right at the patient's bedside. The company's future revenue depends on how widely hospitals implement this innovative technology. This chart shows how investors assess the potential of this new approach in neurology and the size of the addressable market.
%20P%2FS%20CeriBell%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-CeriBell-Inc.&v=1772556835151 "The graph of the company's future (projected) P/S CeriBell Inc.")
Future (projected) P/S of the market segment - Neuro
CeriBell has developed a portable electroencephalography (EEG) system for rapid seizure diagnosis in critically ill patients. This chart compares the company's estimated future sales with those of other neuroscience companies. It reflects investor expectations for the adoption of this innovative technology in emergency and intensive care units.
%20P%2FS%20market%20segment%20graph%20-%20Neuro&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Neuro&v=1772556835221 "Future (projected) P/S market segment graph - Neuro")
Future (projected) P/S of the market as a whole
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures using a portable EEG. The company's growth depends on the adoption of this technology in emergency departments. CeriBell's success exemplifies how medical startups can improve treatment outcomes and create new markets, as illustrated in this chart.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772556835258 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales CeriBell Inc.
CeriBell, Inc. has developed an innovative portable system for rapid diagnosis and monitoring of epileptic seizures right at the bedside. This chart is intended to reflect the commercialization of this device, showing revenue from its sales to hospitals and emergency departments seeking to improve diagnostic quality.
Sales of companies in the market segment - Neuro
CeriBell, Inc. has developed and commercialized the world's first system for rapid, point-of-care electroencephalogram (EEG) monitoring, enabling the rapid diagnosis of seizures. This chart shows overall sales in the neurotechnology sector, illustrating how innovative devices can revolutionize emergency medical care.
Overall market sales
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures right at the patient's bedside. This economic growth impacts CeriBell through the ability of hospitals, particularly intensive care units, to invest in new equipment that can save lives and improve treatment outcomes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company CeriBell Inc.
CeriBell has developed an innovative portable system for rapid diagnosis and monitoring of epileptic seizures right at the patient's bedside. The company's future revenue depends on the implementation of this technology in hospitals and emergency departments. This chart shows analysts' forecasts for the growing demand for fast and accurate diagnostic methods in neurology.
%20sales%20of%20the%20company%20CeriBell%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-CeriBell-Inc.&v=1772556835358 "Schedule of future (projected) sales of the company CeriBell Inc.")
Future (projected) sales of companies in the market segment - Neuro
CeriBell, Inc. has developed a portable system for rapid diagnosis and monitoring of epileptic seizures. This chart shows projected revenue for the entire medical device sector. While it reflects general trends, for CeriBell, the speed of adoption of its innovative technology in emergency departments and intensive care units is more important.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Neuro&v=1772556835381 "Schedule of future (projected) sales of companies in the market segment - Neuro")
Future (projected) sales of the market as a whole
CeriBell develops and markets an innovative system for the rapid diagnosis of epileptic seizures. Demand for its products depends on the willingness of hospitals, especially emergency departments, to implement new technologies. This dynamic, reflecting the state of the economy, impacts healthcare budgets. Economic stability allows them to invest in cutting-edge equipment to improve the quality of care.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772556835393 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality CeriBell Inc.
CeriBell has developed an innovative system for the rapid diagnosis of epileptic seizures. This chart, for such a young medical company, reflects its path to profitability. It shows the balance between the costs of producing and marketing its unique product and the revenue generated, illustrating its effective penetration into the conservative medical market.
Market segment marginality - Neuro
CeriBell has developed an innovative system for rapid diagnosis of epileptic seizures at the bedside. For a company bringing a breakthrough medical product to market, effective commercialization is crucial. This chart shows its operational structure compared to other medical device manufacturers, reflecting its path to widespread adoption of the technology.
Market marginality as a whole
CeriBell is developing and commercializing a rapid EEG monitoring system for use in intensive care units, enabling rapid seizure detection. The company's profitability depends on hospital adoption of its technology. This total market return chart highlights how CeriBell is addressing a critical unmet need in neurology, which could enable rapid growth in the specialized medical market.
Employees in the company, segment and market as a whole
Number of employees in the company CeriBell Inc.
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures at the bedside. This chart shows the growth of its commercial and technical teams. This increase directly reflects the efforts to implement this new technology in emergency and intensive care units, where speed of diagnosis is critical.
Share of the company's employees CeriBell Inc. within the market segment - Neuro
This graph illustrates CeriBell's innovative approach to neuroscience. The company's staff in this niche sector is focused on the development and commercialization of its rapid EEG monitoring system. This team created a portable device that allows emergency room physicians to quickly diagnose seizures, potentially saving patients' lives.
Number of employees in the market segment - Neuro
CeriBell has developed an innovative system for rapid diagnosis and monitoring of epileptic seizures right at the patient's bedside. This device has the potential to save lives by speeding up treatment. This graph illustrates how breakthroughs in neurotechnology are creating new markets and requiring specialists at the intersection of medicine, engineering, and software.
Number of employees in the market as a whole
CeriBell, Inc. has developed a portable system for rapid diagnosis of epileptic seizures. Its market is emergency departments. Demand for its products is driven by hospitals' desire to improve the quality and speed of diagnosis, rather than by economic cycles, as reflected in this chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company CeriBell Inc. (CBLL)
CeriBell developed a portable EEG machine for rapid diagnostics in emergency departments. This chart shows how the market values medical innovations that solve a critical problem. The high market capitalization per employee suggests that the company's value lies in its patented technology, which can save lives, rather than in its scale.
%20of%20the%20company%20CeriBell%20Inc.%20(CBLL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-CeriBell-Inc.-CBLL&v=1772556835614 "Chart of market capitalization per employee (in thousands of dollars) of the company CeriBell Inc. (CBLL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Neuro
CeriBell has developed an innovative system for rapid diagnosis of epileptic seizures. In the MedTech sector, high market capitalization per employee reflects breakthrough technology. The chart shows the market premium the company places on its potential to change the standards of emergency neurological care.
%20by%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Neuro&v=1772556835625 "Market capitalization per employee (in thousands of dollars) by market segment - Neuro")
Market capitalization per employee (in thousands of dollars) for the overall market
CeriBell, Inc. has developed a portable system for rapid diagnosis of epileptic seizures. This graph shows the high value per employee, typical for breakthrough medical technologies. The company's value is determined by the uniqueness of its product, its patents, and its potential to change the standards of emergency neurological care.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772556835637 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company CeriBell Inc. (CBLL)
CeriBell is a medical technology company that has created a portable and fast EEG monitor for diagnosing silent epileptic seizures in intensive care units. This graph shows how successfully the company is commercializing this innovation. Revenue per employee will increase if their lifesaving device becomes standard in hospitals.
%20Chart%20CeriBell%20Inc.%20(CBLL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-CeriBell-Inc.-CBLL&v=1772556835658 "Company Profit Per Employee (in thousands of dollars) Chart CeriBell Inc. (CBLL)")
Profit per employee (in thousands of dollars) in the market segment - Neuro
CeriBell is developing an innovative rapid EEG monitoring system for intensive care units. It enables the rapid diagnosis of silent seizures. This graph demonstrates how effectively the company is monetizing this cutting-edge medical technology. It serves as a benchmark for assessing how successfully the CeriBell team is bringing its niche product to market compared to other neurodiagnostic startups.
%20in%20the%20market%20segment%20-%20Neuro&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Neuro&v=1772556835670 "Chart of profit per employee (in thousands of dollars) in the market segment - Neuro")
Profit per employee (in thousands of dollars) for the market as a whole
CeriBell (CBLL) has developed a portable EEG (electroencephalograph) system for rapid diagnostics in emergency departments. It's an innovative medical device. This graph (likely negative at this stage) shows how close the company is to commercial success. Each R&D and sales employee is expensive, and this figure will only begin to grow if hospitals begin purchasing their expensive equipment en masse.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772556835680 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee CeriBell Inc. (CBLL)
CeriBell has developed a portable system for rapid diagnosis of epileptic seizures. This chart shows the company's progress in bringing this innovative medical product to market. Increased revenue per employee will depend on the successful implementation of this technology in hospitals and emergency departments.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-CeriBell-Inc.-CBLL&v=1772556835691 "Sales chart per company employee CeriBell Inc. (CBLL)")
Sales per employee in the market segment - Neuro
CeriBell develops and markets a portable EEG (electroencephalogram) system for rapid diagnostics in emergency departments. This graph shows the average revenue per employee in the segment, demonstrating how productive their team is in promoting this innovative medical device in the conservative healthcare market.
Sales per employee for the market as a whole
CeriBell is a company that produces an innovative rapid EEG monitoring system. It's a portable device that allows emergency room physicians to quickly diagnose seizures. It's a high-tech medical device. This chart shows how their R&D and sales teams generate high revenue by selling this unique device to hospitals.
Short shares by company, segment and market as a whole
Shares shorted by company CeriBell Inc. (CBLL)
CeriBell is a medical company that has developed a portable EEG system for the rapid diagnosis of neurological conditions (such as epilepsy). The bearish sentiment seen in this chart may reflect concerns about the speed of market adoption. Bears are betting that hospitals will be slow to adopt this new, expensive technology.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-CeriBell-Inc.-CBLL&v=1772556835736 "Short Shares Chart for the Company CeriBell Inc. (CBLL)")
Shares shorted by market segment - Neuro
CeriBell is developing an innovative EEG (electroencephalogram) system for rapid diagnostics in emergency departments (for example, for seizures). This chart reflects the general sentiment in the sector. It reflects the high level of investor skepticism toward medical startups attempting to introduce new, expensive equipment into conservative hospital environments.
Shares shorted by the overall market
CeriBell (CBLL) produces an innovative EEG device for emergency medicine. It's a critical device. But it's a *new* technology. When this market fear graph rises, investors fear that hospitals will freeze *all* capital budgets during a recession. They'll prefer old methods to purchasing expensive new equipment, which will slow CBLL's growth.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator CeriBell Inc. (CBLL)
CeriBell (CBLL) is a medical device company that developed a portable EEG (electroencephalograph) system for rapid stroke and seizure diagnosis in emergency rooms. This chart measures hype. It shows "overheating" (above 70) on news of the rapid adoption of their technology in hospitals or "overselling" (below 30) during waiting periods.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-CeriBell-Inc.-CBLL&v=1772556835762 "RSI 14 indicator chart for the company's stock CeriBell Inc. (CBLL)")
RSI 14 Market Segment - Neuro
CeriBell (CBLL) has developed a portable and fast EEG device that allows emergency room physicians to quickly diagnose silent seizures (convulsions). This graph measures the pulse of the Neurology/Medical Equipment sector. It helps distinguish CeriBell's unique commercial success from the general "overheating" or "overselling" of the entire medtech industry.
RSI 14 for the overall market
CeriBell (CBLL) produces medical equipment. This chart shows that its business is "defensive." Demand for its products (fast EEG) isn't driven by euphoria or panic—it's driven by diagnostic needs. During times of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CBLL (CeriBell Inc.)
CeriBell (CBLL) is a medical technology company that developed the world's first portable and fast EEG (electroencephalogram) system for emergency and intensive care units. This chart shows the average 12-month Wall Street forecast. It reflects analysts' estimates of hospital adoption of this innovative diagnostic system.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CBLL-CeriBell-Inc.&v=1772556835813 "A chart showing analyst consensus forecasts for the expected stock price. CBLL (CeriBell Inc.)")
The difference between the consensus estimate and the actual stock price CBLL (CeriBell Inc.)
CeriBell (CBLL) is a medical technology startup that has created a portable EEG monitor (electroencephalograph) for emergency rooms, enabling rapid seizure diagnosis. This chart is a barometer of their R&D. It measures the gap between the price and the consensus target, reflecting the high, yet speculative, potential analysts see in their breakthrough diagnostic.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CBLL-CeriBell-Inc.&v=1772556835846 "A chart showing the difference between the consensus forecast and the actual stock price. CBLL (CeriBell Inc.)")
Analyst consensus forecast for stock prices by market segment - Neuro
CeriBell (CBLL) is a medical company that has developed "EEG for emergency rooms." Its portable system allows emergency room physicians to quickly diagnose silent (non-convulsive) seizures. This chart shows analysts' overall expectations across the neuroscience sector. It reflects whether experts believe there will be increased demand for rapid diagnostics in intensive care units.
Analysts' consensus forecast for the overall market share price
CeriBell is a medical device company that has developed an innovative portable EEG system for the rapid diagnosis of "hidden" epileptic seizures in intensive care units. This chart shows the overall risk appetite. For CeriBell, as a company with a disruptive, standard-changing technology, overall market optimism is important for funding commercialization and hospital adoption.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index CeriBell Inc.
CeriBell (CBLL) is a medtech company that has simplified EEG. They've created a portable, fast brain monitoring system that allows ICU doctors to quickly diagnose silent seizures. This graph is an adoption indicator. It measures their ability to convince hospitals to buy their (expensive) device and switch to their (high-margin) disposable headset.
AKIMA Market Segment Index - Neuro
CeriBell (CBLL) is a medtech innovator in neurology; the company developed the world's first portable EEG system for emergency departments, enabling instant seizure diagnosis. This composite metric evaluates medtech companies. The graph shows the average value for the segment. This benchmark: how does this breakthrough technology (CBLL) differentiate it from the average competitor?
The AKIM Index for the overall market
CeriBell is the developer of a portable EEG system for rapid seizure diagnosis in critically ill patients. It uses AI. This chart, which reflects the market average, is just a backdrop. It helps assess how this story of hospital adoption compares to overall macroeconomic trends in MedTech.
